NERVGEN PHARMA CORP. Form 40-F: Annual report of Canadian issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-31: Form 40-F; Period of report 2025-12-31; Description 40-F; Document tmb-20251231x40f.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-31 | 40-F | 2025-12-31 | 40-F | tmb-20251231x40f.htm |